SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-007350
Filing Date
2022-05-05
Accepted
2022-05-05 16:01:44
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20220505x8k.htm   iXBRL 8-K 44910
2 EX-99.1 xncr-20220505xex99d1.htm EX-99.1 182586
3 GRAPHIC xncr-20220505xex99d1001.jpg GRAPHIC 8036
  Complete submission text file 0001558370-22-007350.txt   370594

Data Files

Seq Description Document Type Size
4 EX-101.SCH xncr-20220505.xsd EX-101.SCH 3146
5 EX-101.LAB xncr-20220505_lab.xml EX-101.LAB 15270
6 EX-101.PRE xncr-20220505_pre.xml EX-101.PRE 9819
8 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20220505x8k_htm.xml XML 4616
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 22896032
SIC: 2834 Pharmaceutical Preparations